Table 2.
Incidence of AE and mortality in patients with both CPFE and lung cancer according to stage and treatment
Total (n = 61) | AE (n = 10) | Mortality (n = 41) | |
Stage | |||
I | 18 | 3 | 10 |
II | 6 | 1 | 2 |
III | 12 | 3 | 9 |
IV | 24 | 3 | 20 |
Unknown | 1 | 0 | 0 |
Treatment | |||
Chemotherapy | 23 | 5 | 18 |
Surgery | 17 | 3 | 10 |
Radiation | 2 | 0 | 1 |
Best supportive care | 11 | 0 | 8 |
Surgery + adjuvant chemotherapy | 6 | 2 | 3 |
Concurrent chemoradiation | 1 | 0 | 1 |
Unknown | 1 | 0 | 0 |
AE, acute exacerbation; CPFE, combined pulmonary fibrosis and emphysema.